Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients

Kidney Int. 2021 Jun;99(6):1496-1498. doi: 10.1016/j.kint.2021.04.006. Epub 2021 Apr 20.
No abstract available

Publication types

  • Letter

MeSH terms

  • BNT162 Vaccine
  • COVID-19 Vaccines*
  • COVID-19*
  • Female
  • Humans
  • Male
  • RNA, Messenger / genetics
  • Renal Dialysis* / adverse effects
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines
  • RNA, Messenger
  • BNT162 Vaccine